Advertisement
U.S. markets closed

Arcturus Therapeutics Holdings Inc. (ARCT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
33.77+0.91 (+2.77%)
At close: 04:00PM EDT
33.77 0.00 (0.00%)
After hours: 04:02PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Upgrade to begin using 40 years of financial statements and get so much more.
 
As of Date: 3/29/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
907.31M842.59M679.59M761.83M636.53M450.38M
Enterprise Value
645.52M581.89M388.32M467.06M339.41M307.45M
Trailing P/E
N/A8.398.436.8968.49N/A
Forward P/E
2.48N/AN/AN/AN/A2.57
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
5.692.932.642.793.168.70
Price/Book (mrq)
3.263.022.392.312.353.09
Enterprise Value/Revenue
4.0923.208.9548.834.261.92
Enterprise Value/EBITDA
-26.71-54.76-26.81-9.126.502.56

Trading Information

Stock Price History

Beta (5Y Monthly) 2.64
52-Week Change 340.88%
S&P500 52-Week Change 327.86%
52 Week High 343.81
52 Week Low 317.52
50-Day Moving Average 336.09
200-Day Moving Average 329.70

Share Statistics

Avg Vol (3 month) 3443.64k
Avg Vol (10 day) 3603.61k
Shares Outstanding 526.92M
Implied Shares Outstanding 626.92M
Float 824.53M
% Held by Insiders 18.81%
% Held by Institutions 192.00%
Shares Short (Mar 15, 2024) 44.21M
Short Ratio (Mar 15, 2024) 48.47
Short % of Float (Mar 15, 2024) 420.81%
Short % of Shares Outstanding (Mar 15, 2024) 415.63%
Shares Short (prior month Feb 15, 2024) 44.52M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 16, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3Nov 16, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -17.82%
Operating Margin (ttm)-59.22%

Management Effectiveness

Return on Assets (ttm)-11.11%
Return on Equity (ttm)-10.83%

Income Statement

Revenue (ttm)166.8M
Revenue Per Share (ttm)6.26
Quarterly Revenue Growth (yoy)-80.80%
Gross Profit (ttm)N/A
EBITDA -75.25M
Net Income Avi to Common (ttm)-29.73M
Diluted EPS (ttm)-1.12
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)292M
Total Cash Per Share (mrq)10.85
Total Debt (mrq)30.22M
Total Debt/Equity (mrq)10.85%
Current Ratio (mrq)4.72
Book Value Per Share (mrq)10.38

Cash Flow Statement

Operating Cash Flow (ttm)-18.1M
Levered Free Cash Flow (ttm)-82.55M